10-Q Filing

STREAMEX CORP. CIK: 1530766 Q1 2021

Filing Information

Form Type	10-Q
Accession Number	`0001185185-21-000686`
Period End Date	20210331
Filing Date	20210517
Fiscal Year	2021
Fiscal Period	Q1
XBRL Instance	biosig20210331_10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 36 Cash Flow Statement 56 Stockholders Equity 32

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$28.27M	USD	Point-in-time
Cash	`Cash`	$22.47M	USD	Point-in-time
Inventory	`InventoryNet`	$649.94K	USD	Point-in-time
Inventory	`InventoryNet`	$768.32K	USD	Point-in-time
Prepaid expenses and vendor deposits	`PrepaidExpenseCurrent`	$209.00K	USD	Point-in-time
Prepaid expenses and vendor deposits	`PrepaidExpenseCurrent`	$301.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$23.33M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$29.34M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$288.56K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$381.40K	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	$356.27K	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	$306.48K	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	$217.90K	USD	Point-in-time
Patents, net	`FiniteLivedIntangibleAssetsNet`	$346.00K	USD	Point-in-time
Patents, net	`FiniteLivedIntangibleAssetsNet`	$341.00K	USD	Point-in-time
Trademarks	`IndefiniteLivedTrademarks`	$1.00K	USD	Point-in-time
Trademarks	`IndefiniteLivedTrademarks`	$1.00K	USD	Point-in-time
Prepaid expenses, long term	`PrepaidExpenseNoncurrent`	$1.00K	USD	Point-in-time
Accounts payable and accrued expenses, related parties (in Dollars)	`AccountsPayableRelatedPartiesCurrent`	$147.00K	USD	Point-in-time
Accounts payable and accrued expenses, related parties (in Dollars)	`AccountsPayableRelatedPartiesCurrent`	$317.00K	USD	Point-in-time
Prepaid expenses, long term	`PrepaidExpenseNoncurrent`	$5.00K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$102.00K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$102.00K	USD	Point-in-time
Total assets	`Assets`	$30.39M	USD	Point-in-time
Total assets	`Assets`	$24.52M	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Accounts payable and accrued expenses, including $147 and $317 to related parties as of March 31, 2021 and December 31, 2020, respectively	`AccountsPayableAndAccruedLiabilitiesCurrent`	$4.72M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Accounts payable and accrued expenses, including $147 and $317 to related parties as of March 31, 2021 and December 31, 2020, respectively	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.46M	USD	Point-in-time
Deferred revenue, short term	`DeferredRevenueCurrent`	-	USD	Point-in-time
Deferred revenue, short term	`DeferredRevenueCurrent`	$32.16K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$73.00K	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$75.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Lease liability, short term	`OperatingLeaseLiabilityCurrent`	$312.69K	USD	Point-in-time
Lease liability, short term	`OperatingLeaseLiabilityCurrent`	$329.92K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.76M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	32.11M	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.90M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	32.11M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.76M	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.11M	USD	Point-in-time
Deferred revenue, long term	`DeferredRevenueNoncurrent`	$29.48K	USD	Point-in-time
Deferred revenue, long term	`DeferredRevenueNoncurrent`	-	USD	Point-in-time
Lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$720.00	USD	Point-in-time
Lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$28.11K	USD	Point-in-time
Total long-term debt	`LiabilitiesNoncurrent`	$57.00K	USD	Point-in-time
Total long-term debt	`LiabilitiesNoncurrent`	$1.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$5.11M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.95M	USD	Point-in-time
Series C 9% Convertible Preferred Stock, $0.001 par value, $1,000 stated value, authorized 4,200 shares, 105 shares issued and outstanding; liquidation preference of $105 as of March 31, 2021 and December 31, 2020	`TemporaryEquityCarryingAmountAttributableToParent`	$105.00K	USD	Point-in-time
Series C 9% Convertible Preferred Stock, $0.001 par value, $1,000 stated value, authorized 4,200 shares, 105 shares issued and outstanding; liquidation preference of $105 as of March 31, 2021 and December 31, 2020	`TemporaryEquityCarryingAmountAttributableToParent`	$105.00K	USD	Point-in-time
Preferred stock,	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock,	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, authorized 200,000,000 shares, 32,114,781 and 30,764,792 issued and outstanding as of March 31, 2021 and December 31, 2020, respectively	`CommonStockValue`	$31.00K	USD	Point-in-time
Common stock, $0.001 par value, authorized 200,000,000 shares, 32,114,781 and 30,764,792 issued and outstanding as of March 31, 2021 and December 31, 2020, respectively	`CommonStockValue`	$32.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$181.34M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$185.17M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-157.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-165.32M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$19.88M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$24.37M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$582.39K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$802.27K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.85M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.17M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$20.46M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$24.52M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$30.39M	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$118.05K	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Cost of goods sold	`CostOfRevenue`	-	USD	1 Quarter
Cost of goods sold	`CostOfRevenue`	$98.62K	USD	1 Quarter
Gross profit	`GrossProfit`	-	USD	1 Quarter
Gross profit	`GrossProfit`	$19.43K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.93M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.27M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$7.86M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$7.27M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$42.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$21.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$12.80M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$8.58M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-12.80M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-8.56M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$40.00K	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$1.00K	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-12.76M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-8.56M	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss	`ProfitLoss`	$-12.76M	USD	1 Quarter
Net loss	`ProfitLoss`	$-8.56M	USD	1 Quarter
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-239.42K	USD	1 Quarter
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.43M	USD	1 Quarter
Net loss attributable to BioSig Technologies, Inc.	`NetIncomeLoss`	$-8.32M	USD	1 Quarter
Net loss attributable to BioSig Technologies, Inc.	`NetIncomeLoss`	$-11.34M	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$5.00K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$2.00K	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.34M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-8.32M	USD	1 Quarter
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.26	USD	1 Quarter
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.46	USD	1 Quarter
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	31.58M	shares	1 Quarter
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	24.39M	shares	1 Quarter

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-12.76M	USD	1 Quarter
Net loss	`ProfitLoss`	$-8.56M	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$42.00K	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$21.00K	USD	1 Quarter
Amortization of right to use assets	`AmortizationOfLeasedAsset`	$111.00K	USD	1 Quarter
Amortization of right to use assets	`AmortizationOfLeasedAsset`	$113.00K	USD	1 Quarter
Equity based compensation	`AllocatedShareBasedCompensationExpense`	$4.41M	USD	1 Quarter
Equity based compensation	`AllocatedShareBasedCompensationExpense`	$2.52M	USD	1 Quarter
Fair value of subsidiary stock issued to acquire research and development from Trek Therapeutics, PBC	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$3.17M	USD	1 Quarter
Fair value of subsidiary stock issued to acquire research and development from Trek Therapeutics, PBC	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$-222.00K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$118.00K	USD	1 Quarter
Vendor deposits	`IncreaseDecreaseInDepositsOutstanding`	$100.00K	USD	1 Quarter
Vendor deposits	`IncreaseDecreaseInDepositsOutstanding`	$-18.00K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$10.00K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-78.00K	USD	1 Quarter
Payment of long term deposit	`IncreaseDecreaseInDeposits`	-	USD	1 Quarter
Payment of long term deposit	`IncreaseDecreaseInDeposits`	$61.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-456.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.26M	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-116.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-112.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.99M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.94M	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.00K	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$130.00K	USD	1 Quarter
Net cash used in investing activity	`NetCashProvidedByUsedInInvestingActivities`	$-20.00K	USD	1 Quarter
Net cash used in investing activity	`NetCashProvidedByUsedInInvestingActivities`	$-130.00K	USD	1 Quarter
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$9.05M	USD	1 Quarter
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from sale of common stock under a At-the-market offering, net of issuance costs	`ProceedsFromOtherEquity`	-	USD	1 Quarter
Proceeds from sale of common stock under a At-the-market offering, net of issuance costs	`ProceedsFromOtherEquity`	$1.30M	USD	1 Quarter
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	-	USD	1 Quarter
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$28.00K	USD	1 Quarter
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	1 Quarter
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$302.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.35M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.33M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-5.79M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$3.39M	USD	1 Quarter
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$12.11M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$15.50M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$22.48M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$28.27M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$22.48M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$12.11M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$28.27M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$15.50M	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	-	USD	1 Quarter
Cash paid during the period for interest	`InterestPaidNet`	-	USD	1 Quarter
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Dividend payable on preferred stock charged to additional paid in capital	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$5.00K	USD	1 Quarter
Dividend payable on preferred stock charged to additional paid in capital	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$2.00K	USD	1 Quarter
Record right-to-use assets and related lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$218.00K	USD	1 Quarter
Record right-to-use assets and related lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	1 Quarter

Stockholders Equity 32 line items

Line Item	Tag	Value	Unit	Period
Options, per share	`ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice`	$2.96	USD	1 Quarter
Sale of common stock under At-the-market offering, transaction expenses (in Dollars)	`PaymentsOfStockIssuanceCosts`	$40.37K	USD	Point-in-time
Preferred Stock, per share	`PreferredStockRedemptionPricePerShare`	$50.00	USD	Point-in-time
Warrants, per share	`ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1`	$6.16	USD	Point-in-time
Warrants, per share	`ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1`	$3.75	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.85M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.17M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$20.46M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	30.76M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	32.11M	shares	Point-in-time
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$1.78M	USD	1 Quarter
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$2.66M	USD	Point-in-time
Common stock issued for services (in Shares)	`StockIssuedDuringPeriodSharesIssuedForServices`	658,868.00	shares	Point-in-time
Common stock issued for services (in Shares)	`StockIssuedDuringPeriodSharesIssuedForServices`	406,692.00	shares	1 Quarter
Common stock issued upon exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$28.00K	USD	1 Quarter
Common stock issued upon exercise of options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	9,375.00	shares	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$1.30M	USD	Point-in-time
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$9.05M	USD	1 Quarter
Sale of common stock (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	251,720.00	shares	Point-in-time
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$4.41M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$742.00K	USD	1 Quarter
Preferred Stock dividend	`DividendsPreferredStock`	$5.00K	USD	1 Quarter
Preferred Stock dividend	`DividendsPreferredStock`	$2.00K	USD	1 Quarter
Net loss	`ProfitLoss`	$-12.76M	USD	1 Quarter
Net loss	`ProfitLoss`	$-8.56M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.85M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.17M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$20.46M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	30.76M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	32.11M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.